How should the usage and dosage of 0.01% atropine sulfate eye drops (EIKANCE) be used in children?
As the incidence of myopia in children continues to increase worldwide, controlling excessive axial growth has become a focus of ophthalmology. 0.01% Atropine Sulfate Eye Drops (EIKANCE) is a low-concentration atropine eye drop specially used for the management of myopia in children. Atropine slows down the progression of myopia by mildly inhibiting ciliary muscle contraction and regulating eyeball growth signals, slowing down the growth of the eye axis. EIKANCE low-concentration design aims to balance efficacy and safety and reduce pupil dilation, photophobia and accommodation disorders that may be caused by traditional atropine.

In terms of usage,EIKANCE is usually taken once a day and is recommended to be used at night. Nighttime eye drops not only reduce the likelihood of daytime vision being affected, but also help children comply with treatment. The usage method requires strict guidance from parents: wash your hands first, gently open the lower eyelid, drop the liquid into the center of the cornea, close your eyes for a few seconds to help the drug evenly distribute, and avoid spilling the liquid or contaminating the eyelids. The entire operation process needs to be gentle and standardized to ensure that the medicinal solution enters the eyeball safely and maximizes the efficacy.
In terms of dosage, the low concentration0.01% means that one drop per eye per day can control the growth of the axial length of the eye. The doctor will develop an individualized medication plan based on the child's age, axial length, myopia progression rate, and previous treatments. Regular reexamination is key, usually every 3 to 6 months to assess changes in axial length and refraction, and adjust medication strategies if necessary. Through scientific and standardized medication, EIKANCE can not only effectively control the progression of myopia, but also minimize the risk of side effects, allowing children to maintain a comfortable vision experience in daily life.
In addition, drug use should be combined with lifestyle management, including increasing outdoor activities, controlling close eye use, maintaining good reading light and electronic screen use time, etc. Comprehensive intervention strategies can significantly improve the effect of myopia control and provide long-term protection for children's visual health.
Reference materials:https://www.eikance.com.au/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)